“…In this respect oestradiol benzoate treatment appears to have a potential application in commercial practice, in particular in those herds using artificial insemination although there is a consistent reduction in ovulation rate which could lead to unacceptably small litter sizes at term. However, the post-treatment concentrations of plasma oestradiol-17ß in the present studies were significantly higher at both dose levels of oestradiol benzoate employed than those previously reported for untreated cyclic and weaned sows in the preovulatory period (Shearer, Purvis, Jenkin & Haynes, 1972; de Wiel et al, 1981 ;Edwards & Foxcroft, 1983), and a further reduction in the dose of oestradiol benzoate might minimize any detrimental side effects without causing a diminished ovuiatory response.…”